Provided by Tiger Fintech (Singapore) Pte. Ltd.

SINO BIOPHARM

4.550
+0.0200.44%
Volume:170.43M
Turnover:770.73M
Market Cap:85.36B
PE:21.78
High:4.620
Open:4.540
Low:4.420
Close:4.530
Loading ...

Sino Biopharm Presents Lung Cancer Drug Trial Data at US Oncology Conference

MT Newswires Live
·
05 Jun

Sino Biopharm Presents Lung Cancer Study Data at American Oncology Conference

MT Newswires Live
·
03 Jun

Sino Biopharmaceutical Limited Presents Promising Phase II Study Results for TQB2868 in Treating Metastatic Pancreatic Cancer at 2025 ASCO Meeting

Reuters
·
29 May

Sino Biopharm Presents Cancer Drug Data at Oncology Conference

MT Newswires Live
·
28 May

Sino Biopharmaceutical Presents Lung Cancer Drug Trial Data at US Oncology Society Meeting

MT Newswires Live
·
23 May

Sino Biopharmaceutical Gets FDA Nod to Market Cancer Drug

MT Newswires Live
·
25 Apr

Sino Biopharmaceutical - Approval for Marketing of Penpulimab Injection by US FDA

THOMSON REUTERS
·
25 Apr

Sino Biopharmaceutical Gets China Nod for Hematologic Tumor Drug Trial

MT Newswires Live
·
10 Apr

BRIEF-Sino Biopharmaceutical Says Tqb3019 (Btk Protac) Approved For Clinical Trial By NMPA

Reuters
·
09 Apr

Sino Biopharmaceutical - Tqb3019 (Btk Protac) Approved for Clinical Trial by Nmpa

THOMSON REUTERS
·
09 Apr

Sino Biopharmaceutical's Anti-Tumor Drug Gets Implied Approval from China

MT Newswires Live
·
04 Apr

BRIEF-Sino Biopharmaceutical Says Positive Results On Phase 3 Study Of Culmerciclib In Combination With Fulvestrant

Reuters
·
24 Mar

Sino Biopharmaceutical - Positive Results on Phase Iii Study of Culmerciclib in Combination With Fulvestrant

THOMSON REUTERS
·
24 Mar

Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$5.52 From HK$6.42, Keeps at Buy

MT Newswires Live
·
21 Mar

Sino Biopharmaceutical's 2024 Attributable Profit Jumps 50%

MT Newswires Live
·
20 Mar

BRIEF-Sino Biopharmaceutical Recommends Payment Of Final Dividend Of HK4 Cents Per Share

Reuters
·
20 Mar

Sino Biopharmaceutical - Recommended Payment of a Final Dividend of HK4 Cents per Share for Year

THOMSON REUTERS
·
20 Mar

Sino Biopharmaceutical - Recommended Payment of a Final Dividend of HK4 Cents per Share

THOMSON REUTERS
·
20 Mar

Sino Biopharmaceutical - FY Revenue RMB28.87 Bln

THOMSON REUTERS
·
20 Mar

Sino Biopharmaceutical's (HKG:1177) earnings have declined over five years, contributing to shareholders 43% loss

Simply Wall St.
·
13 Mar